Clinical Trials on Urological Malignancies
Total 18616 results
-
Hanmi Pharmaceutical Company LimitedCompletedAdvanced Solid MalignanciesKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompletedAdvanced Solid MalignanciesKorea, Republic of
-
AstraZenecaCompletedAdvanced Solid MalignanciesRussian Federation, Germany
-
Novartis PharmaceuticalsTerminated
-
AstraZenecaCompleted
-
M.D. Anderson Cancer CenterNot yet recruitingMyeloid Malignancies | Lymphodepleting ChemotherapyUnited States
-
Shanghai Escugen Biotechnology Co., LtdEscugen (Australia) Biotechnology Pty LtdNot yet recruitingB-cell Lymphoid Malignancies
-
BeiGeneRecruitingMature B-Cell MalignanciesUnited States, Italy, Australia, New Zealand, Spain, Germany, United Kingdom
-
BeiGeneActive, not recruitingMature B-cell MalignanciesChina
-
Shanghai Junshi Bioscience Co., Ltd.CTI Clinical Trial and Consulting Services; TopAlliance Biosciences, Inc.WithdrawnMalignancies | Previously Treated, Advanced
-
Kiromic, Inc.WithdrawnCancer | Metastatic Solid Malignancies
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
Eisai Inc.CompletedSolid Tumor Malignancies, CancerUnited States
-
PfizerCompletedAdvanced Non-Hematologic MalignanciesUnited Kingdom
-
New Mexico Cancer Care AllianceCompletedAdvanced Solid Tumor MalignanciesUnited States
-
M.D. Anderson Cancer CenterReata Pharmaceuticals, Inc.CompletedSolid Tumors | Lymphoid MalignanciesUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory Hematological MalignanciesChina
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
AstraZenecaParexelCompletedSolid and Hematological MalignanciesGermany
-
Fondazione EMN Italy OnlusCompletedHEMATOLOGIC MALIGNANCIESItaly
-
University of California, DavisCompletedHematologic MalignanciesUnited States
-
AdaptimmuneTerminatedSolid and Hematological MalignanciesUnited States, Canada
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
Sinocelltech Ltd.RecruitingRelapsed or Refractory Hematologic MalignanciesChina
-
Vanda PharmaceuticalsUnknownRelapsed or Refractory Hematologic MalignanciesUnited States
-
Washington University School of MedicineRecruitingPediatric Hematologic MalignanciesUnited States
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineCompletedMyeloid Hematological MalignanciesUnited States
-
Centre Hospitalier Universitaire de BesanconTerminatedHematological Malignancies BFrance
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Malignancies | Hematologic MalignanciesUnited States
-
Precision BioSciences, Inc.RecruitingHematologic Malignancy | CD19 Expressing MalignanciesUnited States
-
Anand B. KarnadCompletedAdvanced B-cell Lymphoid MalignanciesUnited States
-
CASI Pharmaceuticals, Inc.CompletedRelapsed or Refractory Hematological MalignanciesCanada
-
National Taiwan University HospitalNot yet recruitingRelapsed/Refractory B-Cell Malignancies
-
Reata, a wholly owned subsidiary of BiogenCompletedAdvanced Solid Tumors | Lymphoid MalignanciesUnited States
-
Sheba Medical CenterAssaf-Harofeh Medical CenterTerminatedBRAIN MALIGNANCIES AFTER RADIATION THERAPYIsrael
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Novartis... and other collaboratorsTerminated
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced/Metastatic Solid MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedSolid Tumors | Advanced MalignanciesUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedAdvanced Solid Tumor MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Non-hematologic MalignanciesUnited States, Canada
-
AstraZenecaMedImmune LLCCompletedCancer | Advanced Solid MalignanciesJapan
-
SCRI Development Innovations, LLCNovartisCompletedAdvanced Malignancies | Refractory MalignancyUnited States
-
German Cancer Research CenterRecruiting
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Lymphoid MalignanciesUnited States
-
Washington University School of MedicineCompletedSolid Tumors | Advanced Gastrointestinal MalignanciesUnited States
-
Constellation PharmaceuticalsNot yet recruitingSolid Tumor | Hematologic Malignancy | Advanced Malignancies